Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

KV9.2 Inhibitors

KV9.2 inhibitors are a class of chemical compounds that specifically target and modulate the activity of KV9.2 channels, which are a subtype of voltage-gated potassium channels. These channels are part of the KV family, which plays a crucial role in controlling the flow of potassium ions across cell membranes. KV9.2 channels belong to the group of electrically silent modulatory subunits that do not form functional channels by themselves. Instead, they co-assemble with other potassium channel subunits, particularly KV2.x channels, to modulate their activity. The inhibition of KV9.2 subunits alters the overall gating properties and ion conductance of the heteromeric channel complex, thus impacting the regulation of membrane potential and ion homeostasis in excitable cells. KV9.2 channels are particularly involved in fine-tuning the excitability of neurons and other electrically active cells.

Chemically, KV9.2 inhibitors are diverse and can exhibit a wide range of molecular structures, including small molecules, peptides, or other complex organic compounds. Their specificity lies in their ability to selectively interact with the KV9.2 subunit within the heteromeric potassium channel complexes, often by altering the conformational dynamics of the pore-forming regions or by stabilizing inactive states. This inhibition can affect the overall conductance properties of the channel complex, leading to changes in the rate and duration of potassium ion flux during action potentials. By modulating the kinetics and dynamics of KV9.2-containing channels, these inhibitors are valuable tools for studying the intricate roles of potassium channels in cellular signaling, ion homeostasis, and the regulation of electrical properties in various cell types, particularly in neural and cardiac tissues. Their design and application in research allow for a deeper understanding of ion channel regulation and their broader physiological functions.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$166.00
$322.00
436
(1)

Puromycin causes premature chain termination during protein synthesis by mimicking an aminoacyl-tRNA, which would lead to a decrease in the full-length KV9.2 protein.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 competitively inhibits BET bromodomains, which could lead to a downregulation of transcription factors and a consequent decrease in KCNS2 gene expression, thereby reducing the levels of KV9.2 protein.